Precision Biosciences (DTIL) Net Margin (QoQ) (2018 - 2026)

Precision Biosciences (DTIL) Net Margin (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,981.90 Bn 66,981.62 Bn -
2 Nanobiotix 1,913.50 Bn 1,913.44 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 472.03 Bn 467.24 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.09 Bn 114.84 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.01 Bn 61.26 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.99 Bn 50.80 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn
10 Precision Biosciences 182.42 Mn 154.13 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -11,535.00
Dec 31, 2025 21.27 Mn
Sep 30, 2025 -8.95 Mn
Jun 30, 2025 -4.98 Mn
Mar 31, 2025 -6.96 Mn
Dec 31, 2024 137,703.00
Sep 30, 2024 -514,647.00
Jun 30, 2024 4,881.00
Mar 31, 2024 2,295.00
Dec 31, 2023 -7,129.00
Sep 30, 2023 7,549.00
Jun 30, 2023 8,178.00
Mar 31, 2023 -4,104.00
Dec 31, 2022 2,662.00
Sep 30, 2022 82,671.00
Jun 30, 2022 9,310.00
Mar 31, 2022 -54,672.00
Dec 31, 2021 -39,317.00
Sep 30, 2021 -12,044.00
Jun 30, 2021 14,679.00